SUNDAY, DECEMBER 17, 2017

Scripps researchers find antibodies to develop HIV vaccine

Researchers from The Scripps Research Institute have discovered the origins of a group of antibodies that fight HIV, which may help them to develop a vaccine to protect people from contracting the virus. Read More »

Mozambique improves comprehensive health care efforts

Multiple government leaders from Mozambique and around the world have offered their support to the nation in creating programs against tuberculosis (TB), AIDS and malaria. Read More »

UNICEF helps launch anti-polio campaign in Pakistan

Health officials will launch an anti-polio campaign in Pakistan’s Federally Administered Tribal Areas (FATA) and Frontier Regions (FR) beginning Thursday. Read More »

UK teenagers urged to receive free meningitis vaccine

Officials at Public Health England have encouraged teenagers living in the United Kingdom to receive their MenACWY vaccine to protect themselves from meningitis and septicaemia, which are on the rise from December to March. Read More »

Scientists detect why influenza vaccines are less effective for seniors

A recent study from researchers at the University of California San Diego (UCSD) and Emory University shows why the influenza vaccine is not as effective in protecting elderly people from contracting the virus. Read More »

FDA gives priority status to PaxVax's cholera vaccine

The U.S. Food and Drug Administration (FDA) recently gave a priority review status to a Biologics License Application for filing and reviewing a single-dose oral cholera vaccine known as Vaxchora. Read More »

California officials say flu vaccine is part of holiday health

California Department of Public Health (CDPH) officials recently stated that the influenza vaccine may be one of the best ways to stay healthy throughout the upcoming holiday season. Read More »

GSK and Monash University partner to invent new vaccine approaches

GlaxoSmithKline (GSK) Australia and Monash University have partnered to create an innovative production method for vaccines at GSK’s new pilot vaccine facility in Boronia. Read More »

Liberian officials provide latest update on Ebola outbreak

Liberian health officials have released the latest Ebola numbers in a report confirming that all individuals who had contact with the last three confirmed human cases have finished their 21-day quarantines and follow-up appointments. Read More »

Massachusetts Medical School identifies new stage of HIV infection

University of Massachusetts Medical School (UMMS) scientists recently detected a new life-cycle stage that is part of HIV infections. Read More »

Global health officials inch closer to eliminating polio

Global health officials have statistics to show they have made significant progress in their efforts toward eradicating polio. Read More »

Ethiopian officials introduce Inactivated Polio Vaccine

With the support of several worldwide health leaders, Ethiopia recently introduced the new Inactivated Polio Virus (IPV) vaccine to protect people from poliomyelitis. Read More »

Vaxart enlists subjects for influenza B tablet vaccine trial

Vaxart Inc., a clinical-stage, privately held biotechnology company that creates oral recombinant vaccines in the form of tablets instead of injections, recently enrolled its first subject in the company’s Phase I human trial for the influenza B tablet vaccine. Read More »

Scientists map the spread of Ebola in West Africa

Scientists recently developed a map that outlines the spread of Ebola in Western Africa, which will help them to better understand how the virus is transmitted. Read More »

University of Alberta study shows peroxisomes fight mosquito-borne viruses

A recent study from the Faculty of Medicine and Dentistry at the University of Alberta shows how peroxisomes may be crucial in the fight against West Nile virus and dengue fever. Read More »

Malaria vaccine study seeks volunteer subjects in Africa

Scientists from Griffith University’s Institute for Glycomics recently opened its enrollment process to volunteers who want to be involved in the malaria vaccine trials scheduled for 2016. Read More »

US and Mexico increase efforts against mosquito-borne illnesses

The United States and Mexico recently stepped up their efforts to fight mosquito-borne diseases that can cause epidemics. Read More »

ViiV Healthcare purchases HIV assets from Bristol-Meyers Squibb

GlaxoSmithKline (GSK) PLC and ViiV Healthcare, its worldwide HIV vaccine and treatment business, recently finalized an agreement to purchase HIV assets from Bristol-Meyers Squibb. Read More »

Spanish researchers seek protection for humans through MERS vaccine in dromedaries

An team of Spanish researchers has tested a vaccine for Middle East respiratory syndrome (MERS) in dromedary camels to better protect people from contracting the potentially fatal disease. Read More »

WHO issues update on efforts to eradicate polio

The Strategic Advisory Group of Experts (SAGE) on vaccinations recently published a report about the progress in eliminating polio and plans for upcoming efforts. Read More »